# The Evira Study: Additional Support During Obesity Treatment

> **NCT06836284** · NA · RECRUITING · sponsor: **Karolinska Institutet** · enrollment: 40 (estimated)

## Conditions studied

- Childhood Obesity
- Treatment Adherence

## Interventions

- **DEVICE:** Digi-physical treatment tool, Evira
- **DRUG:** Obesity medication with liraglutide or semaglutide

## Key facts

- **NCT ID:** NCT06836284
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-13
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06836284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06836284, "The Evira Study: Additional Support During Obesity Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06836284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*